16-2110116-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001009944.3(PKD1):c.5051C>T(p.Ser1684Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00187 in 1,609,580 control chromosomes in the GnomAD database, including 52 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S1684S) has been classified as Likely benign.
Frequency
Consequence
NM_001009944.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.5051C>T | p.Ser1684Leu | missense_variant | 15/46 | ENST00000262304.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.5051C>T | p.Ser1684Leu | missense_variant | 15/46 | 1 | NM_001009944.3 | P5 |
Frequencies
GnomAD3 genomes AF: 0.00918 AC: 1397AN: 152220Hom.: 19 Cov.: 34
GnomAD3 exomes AF: 0.00259 AC: 629AN: 242742Hom.: 13 AF XY: 0.00192 AC XY: 255AN XY: 132648
GnomAD4 exome AF: 0.00110 AC: 1602AN: 1457242Hom.: 33 Cov.: 35 AF XY: 0.000927 AC XY: 672AN XY: 724844
GnomAD4 genome AF: 0.00920 AC: 1402AN: 152338Hom.: 19 Cov.: 34 AF XY: 0.00898 AC XY: 669AN XY: 74490
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Polycystic kidney disease, adult type Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 02, 2019 | - - |
Polycystic kidney disease Benign:1
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKD1 p.Ser1684Leu variant was identified in 2 of 534 proband chromosomes (frequency: 0.0037) from individuals or families with (Bataille 2011, Rossetti 2012). The variant was also identified in dbSNP (ID: rs139520275) “with likely benign allele,” ClinVar (as likely benign by Prevention Genetics), and ADPKD Mutation Database (4x as likely neutral, found with a truncating mutation). The variant was not identified in GeneInsight-COGR, LOVD 3.0, PKD1-LOVD, databases. The variant was identified in control databases in 901 of 269958 chromosomes at a frequency of 0.003338 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Consortium Feb 27, 2017). The variant was identified in the following populations at a frequency greater than 1%: African in 807 of 23162 chromosomes (freq: 0.035). In addition we cannot be certain that data from control databases is specific to PKD1 and not from one of the six PKD1 pseudogenes. Bataille (2011) classify the variant as a polymorphism. The p.Ser1684Leu residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. The variant is located with the PKD domain Polycystin cation channel PKD/Chitinase domain functional domains, but this is also uninformative. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
Autosomal dominant polycystic kidney disease Benign:1
Likely benign, criteria provided, single submitter | research | Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research | Jan 01, 2019 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 13, 2020 | This variant is associated with the following publications: (PMID: 22008521) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at